 | • レポートコード：QY2207C0820 • 出版社/出版日：QYResearch / 2022年7月8日 • レポート形態：英文、PDF、79ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| #VALUE! |
Market Analysis and Insights: Global Chidamide API MarketDue to the COVID-19 pandemic, the global Chidamide API market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 0.98 accounting for % of the Chidamide API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Pharmaceutical segment is altered to an % CAGR throughout this forecast period.
China Chidamide API market size is valued at US$ million in 2021, while the US and Europe Chidamide API are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Chidamide API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Chidamide API include GNT Biotech & Medicals Corporation and Shenzhen Chipscreen etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Chidamide API capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Chidamide API by region (region level and country level), by company, by Purity and by Application. from 2017 to 2022 and forecast to 2028.
Global Chidamide API Scope and Segment
Chidamide API market is segmented by Purity and by Application. Players, stakeholders, and other participants in the global Chidamide API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Purity and by Application for the period 2017-2028.
Segment by Purity
0.98
0.99
Others
Segment by Application
Pharmaceutical
Scientific Research
By Company
GNT Biotech & Medicals Corporation
Shenzhen Chipscreen
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Chidamide API Product Introduction
1.2 Market by Purity
1.2.1 Global Chidamide API Market Size by Purity, 2017 VS 2021 VS 2028
1.2.2 0.98
1.2.3 0.99
1.2.4 Others
1.3 Market by Application
1.3.1 Global Chidamide API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical
1.3.3 Scientific Research
1.4 Study Objectives
1.5 Years Considered
2 Global Chidamide API Production
2.1 Global Chidamide API Production Capacity (2017-2028)
2.2 Global Chidamide API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Chidamide API Production by Region
2.3.1 Global Chidamide API Historic Production by Region (2017-2022)
2.3.2 Global Chidamide API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Chidamide API Sales in Volume & Value Estimates and Forecasts
3.1 Global Chidamide API Sales Estimates and Forecasts 2017-2028
3.2 Global Chidamide API Revenue Estimates and Forecasts 2017-2028
3.3 Global Chidamide API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Chidamide API Sales by Region
3.4.1 Global Chidamide API Sales by Region (2017-2022)
3.4.2 Global Sales Chidamide API by Region (2023-2028)
3.5 Global Chidamide API Revenue by Region
3.5.1 Global Chidamide API Revenue by Region (2017-2022)
3.5.2 Global Chidamide API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Chidamide API Production Capacity by Manufacturers
4.2 Global Chidamide API Sales by Manufacturers
4.2.1 Global Chidamide API Sales by Manufacturers (2017-2022)
4.2.2 Global Chidamide API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Chidamide API in 2021
4.3 Global Chidamide API Revenue by Manufacturers
4.3.1 Global Chidamide API Revenue by Manufacturers (2017-2022)
4.3.2 Global Chidamide API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Chidamide API Revenue in 2021
4.4 Global Chidamide API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Chidamide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Chidamide API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Purity
5.1 Global Chidamide API Sales by Purity
5.1.1 Global Chidamide API Historical Sales by Purity (2017-2022)
5.1.2 Global Chidamide API Forecasted Sales by Purity (2023-2028)
5.1.3 Global Chidamide API Sales Market Share by Purity (2017-2028)
5.2 Global Chidamide API Revenue by Purity
5.2.1 Global Chidamide API Historical Revenue by Purity (2017-2022)
5.2.2 Global Chidamide API Forecasted Revenue by Purity (2023-2028)
5.2.3 Global Chidamide API Revenue Market Share by Purity (2017-2028)
5.3 Global Chidamide API Price by Purity
5.3.1 Global Chidamide API Price by Purity (2017-2022)
5.3.2 Global Chidamide API Price Forecast by Purity (2023-2028)
6 Market Size by Application
6.1 Global Chidamide API Sales by Application
6.1.1 Global Chidamide API Historical Sales by Application (2017-2022)
6.1.2 Global Chidamide API Forecasted Sales by Application (2023-2028)
6.1.3 Global Chidamide API Sales Market Share by Application (2017-2028)
6.2 Global Chidamide API Revenue by Application
6.2.1 Global Chidamide API Historical Revenue by Application (2017-2022)
6.2.2 Global Chidamide API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Chidamide API Revenue Market Share by Application (2017-2028)
6.3 Global Chidamide API Price by Application
6.3.1 Global Chidamide API Price by Application (2017-2022)
6.3.2 Global Chidamide API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Chidamide API Market Size by Purity
7.1.1 North America Chidamide API Sales by Purity (2017-2028)
7.1.2 North America Chidamide API Revenue by Purity (2017-2028)
7.2 North America Chidamide API Market Size by Application
7.2.1 North America Chidamide API Sales by Application (2017-2028)
7.2.2 North America Chidamide API Revenue by Application (2017-2028)
7.3 North America Chidamide API Sales by Country
7.3.1 North America Chidamide API Sales by Country (2017-2028)
7.3.2 North America Chidamide API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Chidamide API Market Size by Purity
8.1.1 Europe Chidamide API Sales by Purity (2017-2028)
8.1.2 Europe Chidamide API Revenue by Purity (2017-2028)
8.2 Europe Chidamide API Market Size by Application
8.2.1 Europe Chidamide API Sales by Application (2017-2028)
8.2.2 Europe Chidamide API Revenue by Application (2017-2028)
8.3 Europe Chidamide API Sales by Country
8.3.1 Europe Chidamide API Sales by Country (2017-2028)
8.3.2 Europe Chidamide API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Chidamide API Market Size by Purity
9.1.1 Asia Pacific Chidamide API Sales by Purity (2017-2028)
9.1.2 Asia Pacific Chidamide API Revenue by Purity (2017-2028)
9.2 Asia Pacific Chidamide API Market Size by Application
9.2.1 Asia Pacific Chidamide API Sales by Application (2017-2028)
9.2.2 Asia Pacific Chidamide API Revenue by Application (2017-2028)
9.3 Asia Pacific Chidamide API Sales by Region
9.3.1 Asia Pacific Chidamide API Sales by Region (2017-2028)
9.3.2 Asia Pacific Chidamide API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Chidamide API Market Size by Purity
10.1.1 Latin America Chidamide API Sales by Purity (2017-2028)
10.1.2 Latin America Chidamide API Revenue by Purity (2017-2028)
10.2 Latin America Chidamide API Market Size by Application
10.2.1 Latin America Chidamide API Sales by Application (2017-2028)
10.2.2 Latin America Chidamide API Revenue by Application (2017-2028)
10.3 Latin America Chidamide API Sales by Country
10.3.1 Latin America Chidamide API Sales by Country (2017-2028)
10.3.2 Latin America Chidamide API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Chidamide API Market Size by Purity
11.1.1 Middle East and Africa Chidamide API Sales by Purity (2017-2028)
11.1.2 Middle East and Africa Chidamide API Revenue by Purity (2017-2028)
11.2 Middle East and Africa Chidamide API Market Size by Application
11.2.1 Middle East and Africa Chidamide API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Chidamide API Revenue by Application (2017-2028)
11.3 Middle East and Africa Chidamide API Sales by Country
11.3.1 Middle East and Africa Chidamide API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Chidamide API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 GNT Biotech & Medicals Corporation
12.1.1 GNT Biotech & Medicals Corporation Corporation Information
12.1.2 GNT Biotech & Medicals Corporation Overview
12.1.3 GNT Biotech & Medicals Corporation Chidamide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 GNT Biotech & Medicals Corporation Chidamide API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 GNT Biotech & Medicals Corporation Recent Developments
12.2 Shenzhen Chipscreen
12.2.1 Shenzhen Chipscreen Corporation Information
12.2.2 Shenzhen Chipscreen Overview
12.2.3 Shenzhen Chipscreen Chidamide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Shenzhen Chipscreen Chidamide API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Shenzhen Chipscreen Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Chidamide API Industry Chain Analysis
13.2 Chidamide API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Chidamide API Production Mode & Process
13.4 Chidamide API Sales and Marketing
13.4.1 Chidamide API Sales Channels
13.4.2 Chidamide API Distributors
13.5 Chidamide API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Chidamide API Industry Trends
14.2 Chidamide API Market Drivers
14.3 Chidamide API Market Challenges
14.4 Chidamide API Market Restraints
15 Key Finding in The Global Chidamide API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer